-
FDA Safety Changes: New Adverse Events Added to Finasteride Label
CME/CE The US Food and Drug Administration has revised the label for finasteride to indicate additional sexual adverse events.
Medscape Education Clinical Briefs, April 2012
-
Change in C diff Antibiotics Yields More Postsurgical Infections
CME Patients undergoing prostate biopsies who were administered a new antibiotic regimen had more than 5 times as many postsurgical infections vs patients administered the previous regimen.
Medscape Education Clinical Briefs, November 2011
-
FDA Approvals: Tadalafil for Benign Prostatic Hyperplasia
CME/CE The US Food and Drug Administration approved tadalafil to treat benign prostatic hyperplasia as well as the combination of this condition with erectile dysfunction.
Medscape Education Clinical Briefs, October 2011
-
Saw Palmetto Extract Shows No Benefit in Improving BPH Outcomes
CME A study found that saw palmetto extract was not beneficial in relieving urinary tract symptoms in men with benign prostate hyperplasia.
Medscape Education Clinical Briefs, October 2011
-
Prevention and Management of TURP-Related Hemorrhage
CME What are the best means to reduce the risk for bleeding associated with TURP? The current review focuses on evidence-based answers to this question.
Nature Reviews Urology, September 2011
-
A 75-Year-Old Man With Anuria and Abdominal Distention
CME A 75-year-old man presents with a 6-week history of lower abdominal pain and distention, bilateral lower-extremity swelling, and weight loss. He has been anuric for 3 days. What is the diagnosis?
Medscape CME Case Presentations, August 2011
-
Formal 1-to-1 Physical Therapy Ineffective to Treat Incontinence After Prostate Surgery
CME Conservative one-to-one physical therapy for urinary incontinence following prostate surgery was no more effective than standard care with pelvic floor exercises.
Medscape Education Clinical Briefs, July 2011
-
Updated BPH Treatment Guideline Released
The American Urological Association has weighed the efficacy of various benign prostate hyperplasia treatments and updated guidelines previously issued in 2003.
Medscape Education Clinical Briefs, February 2011
-
Management of BPH and Prostate Cancer Reviewed
An overview of benign prostatic hyperplasia and prostate cancer management aimed at primary care physicians notes that watchful waiting or active surveillance are options in selected patients.
Medscape Education Clinical Briefs, November 2010
-
Dihydrotestosterone May Not Affect Prostate Growth But May Reduce BMD
In a study of healthy older men, dihydrotestosterone treatment for 24 months did not affect prostate growth but caused a decrease in spinal, but not hip, bone mineral density.
Medscape Education Clinical Briefs, November 2010
-
Urinary Tract Symptoms Reduced With Long-Term Therapy in Patients With BPH
Based on a systematic review, a 5-alpha-reductase inhibitor vs placebo and active comparators improves long-term urinary tract symptoms associated with benign prostatic hyperplasia.
Medscape Education Clinical Briefs, October 2010
-
FDA Approves Dutasteride/Tamsulosin Combo Pill for BPH
The FDA has approved a single-capsule formulation of 0.5 mg dutasteride and 0.4 mg tamsulosin for symptomatic BPH in men with an enlarged prostate.
Medscape Education Clinical Briefs, June 2010
-
Surgical Management of Benign Prostatic Hyperplasia: Current Evidence
The surgical management of BPH is evolving at a rapid rate, with several new procedures available that challenge transurethral resection of the prostate as the standard surgical treatment.
Nature Clinical Practice Urology, October 2008
-
Highlights of the American Urological Association (AUA) 2008 Annual Meeting
Read our clinically focused reviews of results from AUA 2008 on a broad range of topics: prostate cancer, BPH, incontinence, and sexual function.
Medscape Urology, August 2008
-
Optimizing Prostate Health: Strategies for Managing Enlarged Prostate and Prostate Cancer Chemoprevention
What are the advantages and disadvantages of treatment options that are currently available?
November 2007
-
A Practical Guide To The Evaluation And Treatment Of Male Lower Urinary Tract Symptoms In The Primary Care Setting
Lower urinary tract symptoms in men are more than just the manifestations of benign prostatic hypertrophy. The current article identifies the best practice for the evaluation and management of men with lower urinary tract symptoms.
International Journal of Clinical Practice, October 2007
-
Lower Urinary Tract Symptoms in Men: Prostate or Bladder? An Introduction for Primary Care Providers
CME/CE This review highlights the underrecognized role of bladder dysfunction in a condition that has long been thought to be exclusively due to obstruction from an enlarged prostate.
Medscape Urology, August 2007
-
Highlights of the American Urological Association (AUA) 2007 Annual Meeting
Read our clinically focused reviews of AUA 2007 results on a broad range of topics: prostate cancer, BPH, incontinence, and sexual function.
Medscape Urology, July 2007
-
Evaluating and Treating Male LUTS in the Primary Care Setting: An Interactive Case
This interactive case makes a point that is sometimes overlooked: Overactive bladder is as common in men as it is in women, and frequently accompanies obstructive symptoms due to prostate enlargement.
Medscape Urology, November 2006
-
From Alpha-Blocker to Prostatectomy: A 51-Year-Old Man With Gradually Worsening LUTS
This case follows a male patient with gradually worsening LUTS from assessment by PCP and treatment with alpha blockers through referral to urologist, urodynamic work-up, and eventual prostatectomy.
Medscape Urology, November 2006
